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Excessive mitochondrial reactive oxygen species (ROS) emission is a critical component
in the etiology of ischemic injury. Complex I and complex III of the electron transport
chain are considered the primary sources of ROS emission during cardiac ischemia and
reperfusion (IR) injury. Several factors modulate ischemic ROS emission, such as an
increase in extra-matrix Ca2+ , a decrease in extra-matrix pH, and a change in substrate
utilization. Here we examined the combined effects of these factors on ROS emission
from respiratory complexes I and III under conditions of simulated IR injury. Guinea pig
heart mitochondria were suspended in experimental buffer at a given pH and incubated
with or without CaCl2 . Mitochondria were then treated with either pyruvate, a complex
I substrate, followed by rotenone, a complex I inhibitor, or succinate, a complex II
substrate, followed by antimycin A, a complex III inhibitor. H2 O2 release rate and matrix
volume were compared with and without adding CaCl2 and at pH 7.15, 6.9, or 6.5
with pyruvate + rotenone or succinate + antimycin A to simulate conditions that may
occur during in vivo cardiac IR injury. We found a large increase in H2 O2 release with
high [CaCl2 ] and pyruvate + rotenone at pH 6.9, but not at pHs 7.15 or 6.5. Large
increases in H2 O2 release rate also occurred at each pH with high [CaCl2 ] and succinate +
antimycin A, with the highest levels observed at pH 7.15. The increases in H2 O2 release
were associated with significant mitochondrial swelling, and both H2 O2 release and
swelling were abolished by cyclosporine A, a desensitizer of the mitochondrial permeability
transition pore (mPTP). These results indicate that ROS production by complex I and by
complex III is differently affected by buffer pH and Ca2+ loading with mPTP opening. The
study suggests that changes in the levels of cytosolic Ca2+ and pH during IR alter the
relative amounts of ROS produced at mitochondrial respiratory complex I and complex III.
Keywords: mitochondrial complex I, mitochondrial complex III, reactive oxygen species, simulated ischemia,
mitochondrial permeability transition pore, Ca2+ , pH

INTRODUCTION
Ischemic injury is a multifactorial process that predisposes to further injury during reperfusion (Camara et al., 2007; Aldakkak
et al., 2008a,b, 2011). One key aspect of ischemic injury is the
increase in mitochondrial production of reactive oxygen species
(ROS) above the antioxidant ability of the endogenous ROS scavenging system (Trachootham et al., 2008; Stowe and Camara,
2009; Camara et al., 2010). Under normal conditions, ROS emission is maintained at a low level, which is important for regular
cellular function. But an increase in ROS emission (more production and less scavenging) during ischemia leads to oxidative
stress and apoptosis that leads to cellular dysfunction and death
(Trachootham et al., 2008).
It is widely acknowledged that the main sources of ROS production (mainly superoxide, O•−
2 ) during cardiac ischemia and
reperfusion (IR) injury are respiratory complex I and complex
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III of the mitochondrial electron transport chain (ETC) (Chen
et al., 2007, 2008; Kim et al., 2012; Musatov and Robinson,
2012); but it is unclear what is the relative contribution of complexes I and III on enhancing ROS generation during IR and
when ROS scavenging systems fail. Unlike the other components of the ETC, these complexes are more prone to electron
leak, even under physiologic conditions due to their electron
transfer mechanisms (Musatov and Robinson, 2012). Thus, during IR, these complexes are prone to self-induced oxidative
damage (Gadicherla et al., 2012), which impairs their activity,
predisposing them to even greater ROS production (Rouslin,
1983; Chen et al., 2007, 2008; Musatov and Robinson, 2012).
The damage to complex I may occur abruptly within 20 min
of ischemia, whereas damage to complex III may occur more
gradually as ischemia proceeds (Rouslin, 1983; Chen et al.,
2007).
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We showed previously in a guinea pig model of ex vivo global
IR injury two distinct time-dependent phases of ROS emission
during ischemia; an early phase of low/moderate accumulation
of ROS, and a late phase of high ROS accumulation, followed
by a surge of ROS during early reperfusion (Kevin et al., 2003;
Camara et al., 2007; Aldakkak et al., 2008a,b, 2011). This twophase release of ROS may correspond with the timing of damage
of complexes I and III as reported by others (Chen et al., 2007).
To understand this, we investigated in a recent isolated mitochondrial study the impact of extreme conditions that might
mimic the period of ischemia and reperfusion on ROS emission
(Aldakkak et al., 2013). We found a large increase in hydrogen
peroxide (H2 O2 ) release when complex III electron transfer was
blocked by antimycin A (AA) in succinate-energized mitochondria incubated in elevated extra-matrix Ca2+ buffer. However,
these studies did not evaluate the impact of changes in buffer pH
and mitochondrial permeability transition pore (mPTP) opening
by excess Ca2+ overload, both of which are important modulating
factors that can occur in mitochondria during IR and contribute
to ROS production.
During cardiac ischemia, cytosolic pH levels decrease (Park
et al., 1999), due in part to increased lactate production via
anaerobic glycolysis, and cytosolic Ca2+ levels rise (Aldakkak
et al., 2011), due in part to reduced Ca2+ sequestration by
the sarcoplasmic reticulum. Mitochondrial Ca2+ levels increase
(Aldakkak et al., 2008a); in part as a result of the increase in
uptake by the mitochondrial Ca2+ uniporter. Matrix pH levels, however, depend on many factors including cytosolic pH,
mitochondrial Na+ /H+ , K+ /H+ , and Na+ /Ca2+ exchange, proton (H+ ) leak, and variable H+ pumping rates by complexes
I, III, IV, and V. In the first 5 min of cardiac ischemia, cytosolic pH in affected cardiomyocytes has been reported to drop
0.5 pH units from the initial pH around 7.15, and eventually to
reach as low as 6.0 with a longer ischemia time (Stamm et al.,
2003; Murphy and Steenbergen, 2008). Interestingly, one study
(Selivanov et al., 2008) demonstrated that pH can directly modulate ROS production from the ETC; they reported that an alkaline
pH increased formation of O•−
2 due to increased stabilization of
the semiquinone radical in the Q cycle of complex III (Selivanov
et al., 2008). However, as cardiac ischemia progresses there is a
gradual decrease in cellular pH (Park et al., 1999) and a gradual
increase in ROS levels (Vanden Hoek et al., 1997; Becker et al.,
1999; Kevin et al., 2003), indicating that factors other than just
pH alone are involved.
The aim of our study was to investigate the combined effects
of pH and elevated Ca2+ on the rate of release of H2 O2 from
mitochondria, using substrates and inhibitors of respiratory complexes, in an attempt to mimic cardiac IR. Specifically, we looked
at the effect of acidic pH and high Ca2+ using two different
combinations of mitochondrial substrate + inhibitor conditions.
We utilized pyruvate + rotenone (ROT) to mimic abundance of
pyruvate with impaired complex I, or succinate + AA to mimic
abundance of succinate with impaired complex III (Turrens and
Boveris, 1980; Kakinuma et al., 1994; Starkov et al., 2004). The
elevation in Ca2+ was to induce mitochondrial matrix Ca2+ overload sufficient to induce mPTP opening to mimic an effect of
cardiac IR injury. We hypothesized that a decrease in pH, to
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further mimic conditions of ischemia, would additionally modulate O•−
generation from complex III and/or complex I as
2
assessed by H2 O2 release in isolated mitochondria.
Mitochondrial inhibitors of complexes I-V can cause either
reduced or enhanced O•−
2 generation depending on their site
of action (Becker et al., 1999). With pyruvate as the substrate,
we chose ROT because it inhibits transfer of electrons from
iron-sulfur (Fe-S) centers in complex I at the binding site for
quinol, thus creating a backup of electrons and a highly reduced
NADH pool. This scenario would mimic IR-induced damage to
complex I proteins to cause impaired electron transfer via Fe-S
centers (Gadicherla et al., 2012). Studies have shown that selective accumulation of succinate is a universal metabolic signature
of ischemia in the heart and is responsible for mitochondrial ROS
production during reperfusion (Lukyanova, 2013; Chouchani
et al., 2014). Therefore, with succinate as the substrate, we chose
AA because it inhibits the quinone -reducing center (Qi ) of complex III to prevent the semiquinone radical formed at the Qo site
from being oxidized. Since this impedes electron transfer to the
Qi site, the semiquinone can then transfer its singlet electron to
O2 to produce O•−
2 at complex III (Starkov and Fiskum, 2001).
With succinate, AA can also enhance O•−
2 generation at complex
I. This scenario mimics damage to complex I plus damage to the
Fe-S peptide of complex III during ischemia when quinol oxidation at the Qo site is limited; this leads to “bypass reactions”
that enhance O•−
2 generation at that site (Lesnefsky et al., 2001;
Muller et al., 2002). We chose not to block complex IV, which
would mimic diminished O2 levels during ischemia, because in
this case it would prevent O•−
2 generation at complex III like the
complex III Qo site inhibitor myxothiazol, while stimulating O•−
2
generation at complex I (Turrens et al., 1985).

MATERIALS AND METHODS
All experiments were performed in accordance with the National
Institutes of Health (NIH) Guide for the Care and Use of
Laboratory Animals (NIH Publication No. 85–23, revised 1996)
and were approved by the Institutional Animal Care and Use
Committee of the Medical College of Wisconsin.
MITOCHONDRIA ISOLATION

Heart mitochondria were isolated from ketamine-anesthetized
(50 mg/kg ip) guinea pigs (250–350 g) as described previously
(Gadicherla et al., 2012; Aldakkak et al., 2013; Blomeyer et al.,
2013). Briefly, ventricles were excised, placed in an isolation buffer (buffer A) that contained (in mM) 200 mannitol,
50 sucrose, 5 KH2 PO4 , 5 MOPS, 1 EGTA, and 0.1% bovine
serum albumin (BSA; all chemicals from Sigma, St. Louis,
MO, USA), with pH adjusted to 7.15 with KOH. Ventricles
were then minced into 1-mm3 pieces. The suspension was
homogenized in isolation buffer containing 5U/ml protease
(Bacillus licheniformis; Sigma), followed by differential centrifugation at 4◦ C, and the final pellet was resuspended in isolation
buffer and kept on ice. Protein content was determined by the
Bradford method. Mitochondrial suspension was adjusted to
yield 12.5 mg protein/ml for experimental purpose. Details of
the experimental approach are provided in the Supplementary
Material.
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Experiments were conducted at room temperature (25◦ C),
with mitochondria (0.5 mg protein/ml) suspended in experimental buffer (buffer B) that contained (in mM) 130 KCl
(EMD Chemicals, Gibbs-town, NJ, USA), 5 K2 HPO4 , 20 MOPS,
0.001 Na4 P2 O7 , and 0.1% BSA. This assured that only 40 μM
EGTA was carried over from the isolation buffer (buffer A)
into the experimental buffer. Based on the experimental protocol and conditions, the buffer pH was specifically adjusted
upward from 6.5 to 6.9 and 7.15 by adding KOH. The respiration buffer contained 0 or 150 μM CaCl2 ; concentrations
of CaCl2 between 20 and 60 μM had no significant effects
on H2 O2 production (Figure S.3) and 100 μM CaCl2 gave
inconsistent data, so these data are not reported. From the
residual EGTA concentration of 40 μM, we estimated 150 μM
CaCl2 to be equivalent to ≈ 220 nmol CaCl2 /mg protein. After
adding CaCl2 (or H2 O), 10 mM Na+ pyruvate or Na+ succinate (Sigma) was added. Then either complex I blocker ROT
(10 μM; Sigma) or complex III blocker AA (5 μM; Sigma) was
added.

RESULTS
EFFECT OF CHANGING BUFFER PH AND Ca2+ ON MITOCHONDRIAL
RELEASE OF H2 O2 AND VOLUME AFTER INHIBITING COMPLEX I IN
PYRUVATE-ENERGIZED MITOCHONDRIA

We first evaluated H2 O2 release rates resulting from ROTinhibited complex I in pyruvate-energized mitochondria at pHs
7.15, 6.9, and 6.5, each with H2 O (control) or with added 150 μM
CaCl2 (Figures 1A–C, 2). In the absence of CaCl2 , adding ROT
caused a modest increase in H2 O2 release rate at each pH. In the
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Increase in H O release
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2
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MITOCHONDRIAL FLUORESCENCE MEASUREMENTS

MITOCHONDRIAL O2 CONSUMPTION

Oxygen consumption was measured polarographically using a
respirometry system (System S 200A; Strathkelvin Instruments,
Glasgow, Scotland). Respiration experiments using pyruvate or
succinate at pH 7.15 and without Ca2+ were initially conducted
to determine the viability of mitochondria for the rest of the
experiments. Respiration was initiated by adding 10 mM complex I substrate Na+ pyruvate or the complex II substrate Na+
succinate. State 3 respiration was measured after adding 250 μM
ADP (Sigma), and state 4 respiration was measured after complete phosphorylation of the added ADP. The respiratory control
index (RCI) was calculated as the ratio of the rate of state 3 to
state 4 respiration. Only mitochondria with an RCI of 10 or above
with pyruvate or an RCI of 3 or above with succinate were used
in the experiments. To assess the effects of pH and extra-matrix
(e) [Ca2+ ]e on O2 consumption (respiration), we added either
H2 O (control) or CaCl2 for a final concentration of 150 μM to the
mitochondrial suspension at three pHs (7.15, 6.9 or 6.5) before
adding substrates.
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Mitochondria were suspended in buffer B in a 1 ml cuvette inside
a spectrophotometer (QM-8; Photon Technology International
(PTI), Birmingham, NJ, USA). The rate of H2 O2 release was measured using Amplex red (12.5 μM; Molecular Probes, Eugene,
OR, USA) and horseradish peroxidase (0.1 U/ml; Sigma) at excitation and emission wavelengths of 530 and 583 nm, respectively. H2 O2 is the direct product of O•−
when catalyzed
2
by O•−
dismutase
(SOD)
in
the
absence
of
nitric oxide.
2
H2 O2 levels were calibrated over a range of 10–200 nM H2 O2
(Sigma) added to buffer B in the absence of mitochondria
and in the presence of Amplex red and horseradish peroxidase.
Mitochondrial volume change (increase/decrease) was assessed
by monitoring changes in 90◦ light scattering at an excitation
and emission wavelength of 520 nm inside the same cuvette-based
PTI.

mitochondria
CaCl2 pyruvate

0

100

200

rotenone

300
time (sec)

FIGURE 1 | Time-dependent changes in H2 O2 release rates in isolated
pyruvate-energized mitochondria after inhibiting complex I with
rotenone (ROT) at a different pH: (A) pH 7.15, (B) pH 6.9, (C) pH 6.5.
Mitochondria were added to buffer at 30 s, CaCl2 at 90 s, pyruvate at 150 s,
and ROT at 270 s. The blue trace represents no added CaCl2 , the red trace
represents added CaCl2 to 150 μM in the presence of 40 μM EGTA
(≈ 220 nmol/mg free Ca2+ ), and the green trace represents added CaCl2 to
150 μM with cyclosporine A (CsA). H2 O2 release was assessed using
amplex red with horseradish peroxidase. Numbers indicate mean values ±
SEM of pmol H2 O2 generated/mg/s. N = 4 each.
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EFFECT OF CHANGING BUFFER PH AND Ca2+ ON MITOCHONDRIAL
RELEASE OF H2 O2 AND VOLUME AFTER INHIBITING COMPLEX III IN
SUCCINATE-ENERGIZED MITOCHONDRIA

We evaluated H2 O2 release rates resulting from adding AA to
succinate-energized mitochondria at pH 7.15, 6.9, or 6.5, without (control) or with added 150 μM CaCl2 (Figures 4A–C, 5).
In the absence of CaCl2 at all pHs tested, adding succinate prior
to adding AA caused an increase in H2 O2 release rate while
later addition of AA reduced succinate-induced H2 O2 release
rate (Figures 4A–C). In the presence of 150 μM CaCl2 without
AA, adding succinate did not significantly increase H2 O2 release.
However, later addition of AA with added CaCl2 (150 μM) caused
a large increase in H2 O2 release rate at all pHs with pH 7.15
showing the highest rate (35.2 ± 1.0 pmol/mg/s), followed by
Frontiers in Physiology | Mitochondrial Research
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presence of 150 μM CaCl2 , adding ROT caused a marked increase
in H2 O2 release rate at pH 6.9 (1.38 ± 0.12 pmol/mg/s) compared
to pH 7.15 (0.37 ± 0.02 pmol/mg/s) or to pH 6.5 (0.28 ± 0.07
pmol/mg/s). Since high Ca2+ is known to induce mPTP opening
(Camara et al., 2010), we tested the hypothesis that the Ca2+ induced H2 O2 increase is a result of mPTP opening. Addition of
cyclosporine A (CsA; 0.5 μM; Sigma) prevented the large increase
in H2 O2 release, which was more apparent at pH 6.9 (0.39 ± 0.04
pmol/mg/s). To further evaluate the role of mPTP, we measured
the corresponding mitochondrial volume changes in pyruvateenergized mitochondria in the same combinations of buffer pH
and CaCl2 with later addition of ROT (Figures 3A–C). Adding
CaCl2 alone did not significantly alter mitochondrial volume
before addition of pyruvate. However, at pH 6.9 (Figure 3B) and
6.5 (Figure 3C), mitochondrial volume significantly increased
with added 150 μM CaCl2 after adding pyruvate, but volume was
not significantly affected at pH 7.15 (Figure 3A). Additionally,
mitochondrial volume did not change significantly in experiments without added CaCl2 . Adding CsA prevented the large
increases in mitochondrial volume; adding ROT stopped any
increases in volume (Figures 3A–C). The effect of adding superoxide SOD on H2 O2 release under these conditions is given in
Supplementary Materials.

rotenone

mitochondria

0
FIGURE 2 | Summary of the effects of pH and added CaCl2 on H2 O2
release rates in pyruvate-energized mitochondria after inhibiting
complex I with ROT. Columns represent mean values ± SEM of pmol
H2 O2 emission/mg/s. P < 0.05 ∗ Significant difference in H2 O2 release rate
at pH 6.9 or pH 6.5 vs. pH 7.15 within the same CaCl2 group. ∗∗ Significant
difference in H2 O2 release rate at pH 6.5 vs. pH 6.9 within the same CaCl2
group. # Significant difference in H2 O2 release rate in 150 μM CaCl2 vs.
0 μM CaCl2 for each pH group. N = 4 each.
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ititochondria
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FIGURE 3 | Time-dependent changes in mitochondrial volume in
isolated pyruvate-energized mitochondria after inhibiting complex I
with ROT at a different pH: (A) pH 7.15, (B) pH 6.9, (C) pH 6.5.
Mitochondria were added to buffer at 30 s, CaCl2 at 90 s, pyruvate at 150 s,
and ROT at 270 s. The blue trace represents no added CaCl2 , the red trace
represents added CaCl2 to 150 μM in the presence of 40 μM EGTA
(≈ 220 nmol/mg free Ca2+ ), and the green trace represents added CaCl2 to
150 μM with cyclosporine A (CsA). Mitochondrial volume was assessed by
measuring changes in 90◦ light scattering. N = 3 each.

pH 6.9 (32.6 ± 0.8 pmol/mg/s), and then by pH 6.5 (23.7 ±
1.6 pmol/mg/s) (Figures 4A–C, 5). Adding CsA prevented the
Ca2+ -induced increase in H2 O2 release rate resulting from AA
treatment at each pH with the least effect on mPTP at pH 7.15.
Because enzyme activity is pH dependent, we examined the effect
of adding SOD to the buffer under the same experimental conditions. The effect of adding SOD on H2 O2 release was minimal
(Figures S.1, S.2). In parallel, we measured the corresponding
mitochondrial volume changes in succinate-energized mitochondria in the same combinations of pH and extra-matrix CaCl2 with
later addition of AA (Figures 6A–C). Adding CaCl2 alone did not
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FIGURE 5 | Summary of the effects of pH and added CaCl2 on rates of
H2 O2 release rate in succinate-energized mitochondria after inhibiting
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FIGURE 4 | Time-dependent changes in H2 O2 release rates in isolated
succinate-energized mitochondria after inhibiting complex III with
antimycin A (AA) at a different pH: (A) pH 7.15, (B) pH 6.9, (C) pH 6.5.
Mitochondria were added to buffer at 30 s, CaCl2 at 90 s, succinate at 150 s,
and AA at 270 s. The blue trace represents no added CaCl2 , the red trace
represents added CaCl2 to 150 μM in the presence of 40 μM EGTA
(≈ 220 nmol/mg free Ca2+ ), and the green trace represents added CaCl2 to
150 μM with CsA. Numbers indicate mean values ± SEM of pmol
H2 O2 generated/mg/s. N = 4 each.

(all of the above experiments were conducted during state 2). In
pyruvate-energized mitochondria (Figure 7A), and before adding
CaCl2 , there was no difference in state 2 respiration among all
pH groups. Adding 150 μM CaCl2 led to an increase in state 2
in the pH 7.15 group only. In succinate-energized mitochondria
(Figure 7B), and before adding CaCl2 , there was no difference
in state 2 respiration among all pH groups. However, adding
150 μM CaCl2 led to similar decreases in state 2 respiration for all
pH groups. States 3 and 4 respiration rates and the respective RCI
values for each pH group without (control) or with addition of
150 μM CaCl2 are summarized (Table 1). Adding 150 μM CaCl2
decreased states 3 and 4 respiration and RCI under each of the
two substrate and three pH conditions, except at pH 7.15 for state
4 respiration with pyruvate where state 4 respiration increased
slightly but significantly. State 3 respiration and RCI were unaffected by pH except in two conditions: (1) pyruvate and 0 μM
CaCl2 , in which they were reduced at pH 6.5, and (2) pyruvate
and 150 μM CaCl2 , in which they were reduced at pH 6.9 and
6.5. State 4 respiration was unaffected by pH except in the condition pyruvate and 150 μM CaCl2 , in which it was reduced at pH
6.9 and 6.5.

DISCUSSION
significantly alter mitochondrial volume before adding succinate
(Figures 6A–C). Later addition of succinate induced a significant
increase in mitochondrial volume at all pHs which was prevented by CsA. Adding AA led to an attenuation of mitochondrial
volume (Figures 6A–C).
EFFECT OF CHANGING BUFFER pH AND Ca2+ ON MITOCHONDRIAL
RESPIRATION IN PYRUVATE AND SUCCINATE-ENERGIZED
MITOCHONDRIA

Because O•−
2 generation is dependent on electron flux through
the ETC and is a product of electron leak at several complexes,
we evaluated the effects of substrate, pH, and [Ca2+ ]e on
mitochondrial respiration during states 2, 3, and 4 respiration
www.frontiersin.org

The main goal of this work was to simulate in isolated heart mitochondria prevailing effects that can occur in cardiac IR injury
such as excess Ca2+ , low pH, and impaired electron transfer
at ETC complexes I and III, and to determine their impact on
release of H2 O2 . In addition, we used either the complex I substrate pyruvate or the complex II substrate succinate to mimic
substrate conditions that may prevail during IR. The first protocol (e.g., Figure 3) was intended to represent less severe IR
injury (pyruvate as substrate, inhibited complex I > complex
III, low Ca2+ loading, pH 7.15, 6.9); the second protocol was
intended to represent more severe IR injury (succinate as substrate, inhibited complex III + complex I, high Ca2+ loading, pH
6.5). Under these latter conditions, H2 O2 release rate was about
10 times higher, and the lower pH with either substrate condition
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FIGURE 6 | Time-dependent changes in mitochondrial volume in
isolated succinate-energized mitochondria after inhibiting complex III
with AA at a different pH: (A) pH 7.15, (B) pH 6.9, (C) pH 6.5.
Mitochondria were added to buffer at 30 s, CaCl2 at 90 s, succinate at 150 s,
and AA at 270 s. The blue trace represents no added CaCl2 , the red trace
represents added CaCl2 to 150 μM in the presence of 40 μM EGTA
(≈ 220 nmol/mg free Ca2+ ), and the green trace represents added CaCl2
with CsA. N = 3 each.

attenuated H2 O2 release. Overall, our results show that in succinate energized mitochondria, increased buffer Ca2+ enhances
mitochondrial H2 O2 release rates resulting from complex I and
III (AA) similarly at each pH, whereas in pyruvate energized
mitochondria, a significant increase in H2 O2 release rate resulting
from complex I (ROT) occurs only at pH 6.9.
COMPLEX I AND COMPLEX III ARE PRIMARY SOURCES OF O•−
2
DURING ISCHEMIA AND REPERFUSION

It is well-documented that reperfusion after ischemia is associated with considerable ROS emission (Vanden Hoek et al., 1997;
Becker et al., 1999; Kevin et al., 2003). It appears paradoxical that
ROS are also produced during ischemia; but total mitochondrial
anoxia is unlikely to exist even with extensive cardiac ischemia
Frontiers in Physiology | Mitochondrial Research

(Becker, 2004). It has been reported that isolated mitochondria
produce H2 O2 when O2 is as low as 0.5 mM (pO2 of about
10 mmHg) (Saborido et al., 2005). Mitochondrial pO2 in vivo is
only about 1–5 mmHg with normoxia, so mitochondria normally
thrive in a low O2 environment. The emission of ROS is due to
excessive O•−
2 generation (likely during early mild ischemia when
the redox potential is high) and to diminished ROS scavenging
(likely during later severe ischemia when the redox potential is
low).
In previous studies of IR injury in guinea pig isolated
hearts, we observed a modest increase in O•−
2 generation during early ischemia (10–15 min) followed by a larger increase
generation during late ischemia (20–30 min) and a
in O•−
2
surge during early reperfusion (Kevin et al., 2003; Riess et al.,
2004; Aldakkak et al., 2008a,b, 2011). Recently, we demonstrated in isolated mitochondria, under conditions simulating
ischemia, that CaCl2 addition in the presence of succinate
resulted in enhanced H2 O2 release when complex III was blocked
(Aldakkak et al., 2013).
It is widely recognized that both mitochondrial complexes
I and III play a crucial role in producing ROS during cardiac
IR injury, particularly with induction of mPTP. “Triggering”
amounts of ROS can be generated in isolated cardiomyocytes by
photoactivation of tetramethylrhodamine derivatives that leads to
membrane depolarization (mPTP induction) and a burst of ROS,
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Table 1 | Effects of increasing concentrations of CaCl2 on states 3, and
4, and respiratory control index (RCI, state 3/state 4) under different
substrate and pH conditions.
Substrate µM CaCl2
State 3

Pyruvate

0
150

State 3

Succinate

0
150

State 4

Pyruvate

0
150

State 4

Succinate

0
150

RCI (state
3/state 4)

Pyruvate

RCI (state
3/state 4)

Succinate

pH 7.15

pH 6.9

13.7 ± 0.8 14.6 ± 0.9

pH 6.5
9.2 ± 1.3*

9.0 ± 1.0‡ 0.9 ± 0.4*‡ 0.5 ± 0.1*‡
12.5 ± 0.5

9.9 ± 3.9

2.0 ± 0.2‡ 1.9 ± 0.3‡

11.4 ± 1.1

1.9 ± 0.3‡

1.1 ± 0.1

1.2 ± 0.1

1.3 ± 0.2

2.3 ± 0.2‡ 0.7 ± 0.3*‡ 0.6 ± 0.2*‡
3.7 ± 0.3

3.2 ± 0.5

2.4 ± 0.3‡ 2.3 ± 0.3‡

3.9 ± 0.4

2.1 ± 0.3‡

0

12.6 ± 0.7 12.0 ± 0.4 7.2 ± 0.6*§

150

4.0 ± 1.1‡ 1.3 ± 0.3*‡ 1.0 ± 0.1*‡

0

3.1 ± 0.5

3.8 ± 0.4

3.5 ± 0.6

150

0.9 ± 0‡

0.9 ± 0‡

0.9 ± 0.0‡

P < 0.05 *Significant difference in states 3 and 4 and RCI in pH 6.9 or pH 6.5
vs. pH 7.15 within the same CaCl group. § Significant difference in RCI in pH 6.5
2

vs. pH 6.9 within the same CaCl2 group. ‡Significant difference in states 3 and
4 and RCI in 150 μM CaCl2 vs. 0 μM CaCl2 for each pH group. Note the marked
effect of 150 μM CaCl2 to depress RCI at each pH and the smaller effect of pH
6.5 with pyruvate and no CaCl2 to reduce RCI.

which is coined “ROS-induced ROS release (RIRR)” (Zorov et al.,
2000). However, inducing mPTP opening with excess CaCl2 in
isolated liver mitochondria did not increase H2 O2 release unless
exogenous NADH was added to the buffer (Batandier et al., 2004).
Because mPTP opening resulted in a ROT-sensitive impairment
of complex I activity, they concluded that mPTP opening is associated with defective electron transfer within complex I, leading
to O•−
2 release at that site. We did not add NADH to the buffer
but we observed an increase in H2 O2 release under either substrate condition when complex I and III inhibitors were used to
mimic some conditions of IR injury. Despite these advances, the
prevailing metabolic conditions during mild vs. severe IR injury
that promote differential dysfunction of the complexes to cause
excess O•−
2 generation and ROS emission in a vicious cycle of
RIRR remain unclear.
In ischemia, decreasing O2 levels and concomitant activation
of glycolysis caused a decrease in pH, increased extra-matrix and
matrix [Ca2+ ], and eventually damage to complexes I and III
due to oxidative stress (Rouslin, 1983). O•−
2 generated under
these conditions is derived in part from complex I through
forward electron transfer (FET) (Starkov et al., 2004). In the
study above (Rouslin, 1983), it was reported that the activity of
complex I decreased markedly after 20 min ischemia and that
this decrease closely paralleled the decrease in mitochondrial O2
uptake with NADH-linked substrates; it was also reported that the
activity of complex III decreased at a more gradual rate during
ischemia and that its rate of decrease paralleled that of succinatesupported O2 uptake. As ischemia progresses, pH drops further
and extra-matrix and matrix Ca2+ levels rise, while substrate utilization switches from primarily pyruvate to mostly succinate,
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which accumulates from 0.2 to 0.4 mM during normoxia to 4–
7 mM during ischemia or hypoxia (Kakinuma et al., 1994; Starkov
et al., 2004). Based on these studies, we used pyruvate + ROT to
approximate the condition of impaired electron transfer via complex I to complex III, and succinate + AA to approximate the
condition of enhanced utilization of succinate at complex II and
impaired electron transfer through complex I (by RET) and III.
Our protocols were also based on a summary of data (Lukyanova,
2013) stating that the switch from normoxia to hypoxia increased
succinate utilization by complex II from about 25–35% to 65–
85% while complex I activity was mostly inhibited. Under this
condition, complex III appears to be damaged by ROS due to
the initial O•−
2 generated at complex I, which is analogous to AA
inhibition of complex III (Musatov and Robinson, 2012). Given
these conditions and the diminished m , ROS production during severe IR injury likely results from FET including complex
II and III. Therefore, our experiments with succinate + AA may
mimic the conditions of O•−
2 generated at both complex I and III
during IR injury.
BIPHASIC EFFECTS OF pH ON mPTP LEADS TO VARYING H2 O2
PRODUCTION FROM COMPLEX I

Adding CaCl2 and lowering pH both modulated H2 O2 production in pyruvate-energized mitochondria after adding ROT
(Figures 1A–C, 2). Based on previous studies showing a distinct
early phase of H2 O2 production during mild ischemia correlated with the timing of complex I damage, we hypothesized
that pyruvate-energized mitochondria with inhibited complex I
and added CaCl2 would show an increased H2 O2 release rate as
buffer pH decreased. Indeed, a sharp rise in H2 O2 production was
observed at pH 6.9 on addition of CaCl2 , which was not seen at
pH 7.15. However, as pH decreased further to 6.5, a rise in H2 O2
did not occur. It is unclear what the exact mechanism is for the
large increase in H2 O2 release in pyruvate-supported mitochondria at pH 6.9 with added CaCl2 . It is important to note that
under these conditions, there was a significant increase in mitochondrial volume, probably indicating mPTP opening. Indeed,
addition of CsA to desensitize mPTP prevented the increase
in mitochondrial volume and reduced H2 O2 release to levels
similar to those observed at pH 7.15. Nonetheless, mPTP opening occurred also at pH 6.5 with high CaCl2 as indicated by
the increase in mitochondrial volume that was prevented with
CsA; but this was not associated with a large increase in H2 O2
release.
mPTP opening can occur during mitochondrial Ca2+ overload (Orrenius et al., 2003), whereas a low mitochondrial pH
is associated with a reduced probability of mPTP opening. For
example, reoxygenation or reperfusion under acidic conditions is
associated with much lower ROS emission (Haworth and Hunter,
1979; Halestrap, 1991; Bernardi et al., 1992). However, a previous study (Halestrap, 1991), with glutamate/malate-energized
mitochondria isolated from rat hearts, showed a graded effect
of pH on the probability of mPTP opening with the least likelihood of opening at pH 6.0 and below. At pHs above 6.0 there
was a significant increase in the probability of mPTP opening. Indeed, at pH 6.5, a Ca2+ -induced increase in volume,
presumably through mPTP opening, was demonstrated to be
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greater than 40% of the increase seen at pH 7.4; and pH 6.9
had approximately 75% of the volume increase seen at pH 7.4
(Halestrap, 1991).
mPTP opening is proposed to increase ROS emission through
three mechanisms: a loss of glutathione leading to decreased ROS
scavenging, a loss of cytochrome c leading to increased reduction of upstream ETC complexes and subsequent electron loss
and diminished scavenging, and an increase in ROS derived from
the α-ketoglutarate dehydrogenase complex due to loss of NAD+
(Camara et al., 2010, 2011; Toledo et al., 2014). In our study different probabilities of mPTP opening at pH 6.9 and 6.5 may be
responsible for the disparity in H2 O2 levels generated at these
two pHs. Limited opening of mPTP at pH 6.5 may be responsible for H2 O2 generation at levels not sufficient to induce RIRR,
whereas at pH 6.9 the increased opening of mPTP may induce
RIRR. Additionally, the lack of increased H2 O2 generation and
mitochondrial volume at pH 7.15, when compared to pH 6.9,
might be related to an increase in inhibition of complex I with
high CaCl2 as pH increases (Sadek et al., 2004; Chen et al., 2010).
The decrease in complex I activity leading to decreased ROS production might in turn prevent RIRR and subsequent opening of
the mPTP (Zorov et al., 2006). Thus, the combined effects of
inhibited complex I activity and mPTP opening at pH 6.9 might
explain the elevation in H2 O2 release rates observed at pH 6.9,
but not at pHs 7.15 and 6.5.
pH-DEPENDENT O•−
2 GENERATION FROM COMPLEXES I AND III AND
STABILITY OF SEMIQUINONE RADICAL

Adding CaCl2 and altering pH also modulated H2 O2 generation in succinate-energized mitochondria with added AA
(Figures 4A–C). With AA, mitochondria in buffer with high
CaCl2 showed a dramatic rise in H2 O2 release at all pHs. The
increase in H2 O2 corresponded to an increase in pH. In addition, an increase in mitochondrial volume occurred at each pH in
the presence of high CaCl2 , and these conditions led to increased
H2 O2 release, suggesting a role for mPTP opening. Indeed, both
the increases in H2 O2 release and volume were inhibited by
adding CsA at each pH. H2 O2 generation under these conditions
is likely caused by FET from complex II through complex III,
because adding AA decreased m , which would prevent RET
from occurring. In this case, the primary source of H2 O2 is that
derived from O•−
2 generated at the Qo site of complex III.
Mitochondrial pH may have a significant role in moderating O•−
2 generation by complex III. Matrix alkalinization (higher
pH) tended to stabilize the semiquinone radical at the Qo
site (Selivanov et al., 2008). This was proposed to result from
decreased binding of H+ ions necessary to drive the Q cycle
forward (Selivanov et al., 2008). Stability of the semiquinone radical leads to increased likelihood of direct transfer of an electron
to an O2 molecule, leading to the formation of O•−
2 (Selivanov
et al., 2008). Additionally, because AA blocks the oxidation of
semiquinone at Qi and the transfer of an electron from the Qo
site, this can lead to increased O•−
2 generation from the Qo site,
which may be analogous to impaired complex III function during ischemia (Chen et al., 2008; Musatov and Robinson, 2012).
Consequently, in our experiments, the increased H2 O2 release
rate at a high pH is possibly related to the increased stability of
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semiquinone leading to increased direct electron donation to O2
to generate O•−
2 .
Ca2+ -INDUCED mPTP OPENING AND MITOCHONDRIAL RESPIRATION

Mitochondrial uncouplers like dinitrophenol tend to increase
respiration to counteract a decline in m due to H+ leak.
But others have reported that it is not unusual for mitochondrial uncouplers or uncoupling events such as mPTP opening
to inhibit succinate-supported state 2 respiration. Mitochondrial
uncouplers can retard succinate oxidation under some conditions
(Papa et al., 1969). In the absence of ROT, and with succinate
in high concentrations (conditions similar to those used in our
study), mitochondrial uncouplers have been found to inhibit succinate oxidation due to the formation of oxaloacetate (Wojtczak
et al., 1969; Vik and Hatefi, 1981; Kotlyar and Vinogradov, 1984;
Drose, 2013).
In our study, the lower state 2 respiration after adding CaCl2
with succinate (Figure 7B) at each pH, may be due to a greater
collapse in m due to the excess influx of Ca2+ . In contrast,
the higher state 2 respiration after adding CaCl2 with pyruvate
(Figure 7A) at pH 7.15 may be a result of enhanced H+ pumping at complex I by this NADH-linked substrate; however, as the
trans-membrane pH potential is increased (and thus the proton
motive force), a faster respiration might not be needed to maintain m . The RCI for pyruvate was reduced at pH 6.5 likely
because of an uncoupling effect due to H+ leak with slower ATP
production (Table 1). The RCI for succinate, which is much lower
than that for pyruvate, appears to stem from the much higher
basal respiratory rate for succinate vs. pyruvate (Figures 7B vs.
7A). In the absence of CaCl2 , mitochondria showed well-coupled
oxidative phosphorylation with both substrates at each pH, except
in pyruvate-energized mitochondria at pH 6.5, in which case the
RCI was lower, indicating relatively less coupling. The effect of
added CaCl2 on states 3 and 4 respirations and RCI with either
substrate or at any pH is likely a result of marked uncoupling due
to mPTP opening (increased mitochondrial volume) because this
was sensitive to CsA (Figures 3, 6).
SUMMARY, CONCLUSION, AND PERSPECTIVE

In conclusion, in our previous studies using the isolated, beating heart model of 30 min global ischemia, we demonstrated two
phases of increased O•−
2 generation, an early phase (10–20 min)
that emits low to moderate O•−
2 levels and a late phase (20–
•−
30 min) that emits higher O•−
2 levels just before a surge in O2
release at the beginning of reperfusion. The present study sheds
novel insights into the modulatory effect of matrix pH in Ca2+ induced mitochondrial H2 O2 release. The early or mild phase of
H2 O2 release due to O•−
2 generation at complex I could be related
to differential effects of pH on the mPTP, which allows H2 O2
production at the pH observed during early or mild ischemia
(pH 6.9) but not at the lower or higher pHs. The late or severe
phase of H2 O2 release due to O•−
2 generation primarily at complex III, but also at complex I, may also be dependent on mPTP
opening, but H2 O2 production is intensified with increasing
pH. Therefore, it is possible that the surge in H2 O2 production
commonly observed on reperfusion results from O•−
2 generated
from complex III as the pH rises gradually with mPTP opening.
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Although both complex I and III contribute simultaneously to
H2 O2 production during IR, our results suggest that the role of
each respiratory complex is not static but rather changes dynamically as the pH changes. Thus, each complex may play a more
prominent role during a certain period of IR. Being cognizant
of this information is important as it can be used to reduce
ROS emission as ischemia progresses by targeting each complex
separately, or possibly by manipulating the pH using Na+ /Ca2+
and/or Na+ /H+ exchange inhibitors, e.g., by maintaining a more
alkaline environment during early ischemia and a more acidic
environment during late ischemia/early reperfusion, to reduce
O•−
2 generation at complex I and III.

POTENTIAL IMITATIONS
Although we have attempted to simulate some of the conditions in mitochondria that may occur during authentic cardiac
IR injury, there are several shortcomings to this approach: (1)
Our experimental design did not allow us to mimic the timing
of ROS production during ischemia, or during reperfusion after
ischemia, or to allow for the possible redox conditions associated
with varying ROS scavenging capacity during IR injury. (2) We
completely blocked electron transfer sites using inhibitors; in vivo
it is known that IR injury impairs electron transfer, but does not
block it completely. (3) IR injury could impede electron transfer
at other sites (e.g., myxothiazol prevents semiquinone formation
at the Qo site), which could inhibit O•−
2 generation at that site,
but stimulate it at another site. (4) On the other hand, IR injury
may cause O•−
2 generation at other sites not examined (e.g., the
flavin site of complex I). (5) Free fatty acids are a normal substrate
for mitochondria and they were absent in this study. (6) The use
of succinate + AA cannot distinguish O•−
2 generation from complex I vs. III without knowledge of the redox state and m or the
presence of ROT to prevent RET. (7) Changes in matrix pH and
Ca2+ during IR injury may not arise solely due to changes in the
cytosol, but rather in the matrix in response to bioenergetic dysfunction and possibly loss of mitochondrial buffering capacity.
(8) It is very difficult to directly assess O•−
2 generation in mitochondria; thus a variation in the redox potential during IR injury
can lead to differential dismutation of O•−
2 to H2 O2 , an additional
factor not assessed in our simulated ischemia conditions.
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